Clarivate Plc opera como una destacada empresa de servicios de información y análisis, que proporciona datos estructurados y perspectivas. Su misión principal ...
Clarivate Plc (NYSE: CLVT) is a global provider of “transformative intelligence,” combining high-value data with analytics and workflow solutions for customers such as academia, government, law firms, and life sciences organizations. The company’s services are designed to help users move from discovery to execution—supporting how research is planned, funded, conducted, ...Clarivate Plc (NYSE: CLVT) is a global provider of “transformative intelligence,” combining high-value data with analytics and workflow solutions for customers such as academia, government, law firms, and life sciences organizations. The company’s services are designed to help users move from discovery to execution—supporting how research is planned, funded, conducted, evaluated, and translated into real-world impact.
From a business perspective, Clarivate operates across several interconnected domains:
- Scholarly and research intelligence: Clarivate offers the Web of Science suite and related tools including InCites and Journal Citation Reports for research discovery, performance evaluation, and analytics. It also provides workflow and publishing support tools such as EndNote, ScholarOne, Converis, and related platforms.
- Life sciences decision support: In this area, products such as Cortellis and Newport Integrity are aimed at helping pharmaceutical and biotechnology organizations monitor competitive landscapes, assess market intelligence, and support development and launch planning.
- Intellectual property (IP) management: The Derwent product line—covering Derwent Innovation, Techstreet, and IP Professional Services—supports customers in evaluating originality, establishing freedom-to-operate boundaries, securing and analyzing patent protection, and understanding the competitive technological landscape.
- Trademark and digital brand protection: Clarivate includes solutions such as CompuMark (trademark screening/search/monitoring) and MarkMonitor (helping enterprises manage and strengthen their digital presence).
Product-wise, Clarivate’s approach typically involves enriching and organizing large-scale datasets and then packaging them into usable workflows—so customers can reduce manual effort, improve decision quality, and ensure better compliance across research, IP, and brand processes. The company’s offerings span the entire research and innovation lifecycle: from literature discovery and citation intelligence to IP analytics and operational support for commercialization.
Cost and delivery model considerations: Clarivate is largely software- and data-enabled, so revenue is generally supported by subscription-style access and enterprise licensing, with expert or service elements layered in where domain expertise is required (for example, in research evaluation and IP-related work). Because its “assets” are information systems, content/data enrichment pipelines, and analytics models, the cost structure often emphasizes platform development, content acquisition/enrichment, and ongoing customer support.
Financially, available market data for CLVT indicates a publicly traded profile with ongoing investment in operations; however, detailed unit economics (e.g., BOM-like breakdown) are not publicly provided in the supplied inputs. In general terms for the sector, major drivers include data processing and curation, cloud/IT infrastructure, and sales/CS costs for enterprise contracts.
Key people: Clarivate’s CEO is Matti Shem Tov (appointed as the company’s next CEO per the provided press-release information). Strategically, the company aligns product roadmaps around expanding data coverage, improving analytics/workflows, and strengthening domain-specific solutions for life sciences and IP.
Wishes/forward outlook (consistent with the company’s mission): customers typically want more complete and timely coverage, faster workflow enablement, better integration into existing research and legal operations, and improved transparency/traceability of the intelligence used for decisions. Clarivate’s stated mission—discovery, protection, and commercialization of research, innovations, and established brands—directly aligns with those priorities.
Plutux no es un asesor de inversiones. Los datos de mercado y el análisis generado por IA son solo informativos y educativos, no asesoramiento de inversión. Aviso legal
InteranualYoY significa Year-over-Year (interanual). Compara el último valor anual con el valor anual anterior para mostrar la fortaleza de la tendencia a largo plazo.
TrimestralQoQ significa Quarter-over-Quarter (intertrimestral). Compara el último trimestre con el trimestre inmediatamente anterior para mostrar cambios de impulso a corto plazo.
IngresosEl dinero total que entró por la puerta principal al vender cosas, antes de pagar una sola factura. Piensa en esto como el gran total de cada compra con tarjeta de los clientes. (YoY compara el rendimiento de este año con el del año pasado, mientras que QoQ compara los tres meses actuales con los tres anteriores).
$2.5B
-4.0%
+0.3%
Beneficio netoEl resultado final absoluto. Si la empresa pagara a cada proveedor, empleado, banquero y recaudador de impuestos, este es el dinero real que queda en su bolsillo al final del día.
$-201.1M
+68.4%
-568.2%
Margen brutoEl margen básico. Si venden unas zapatillas de 100 dólares, este porcentaje indica cuánto de ese precio es ganancia justo después de pagar el caucho y los cordones, pero antes de pagar el alquiler de la tienda o los anuncios de televisión.
+66.0%
+0.1%
+1.8%
Margen operativoLa puntuación de eficiencia del 'trabajo diario'. De cada dólar que gasta un cliente, esto muestra cuántos centavos mantiene la empresa después de fabricar el producto Y pagar todos los gastos generales corporativos (como salarios, marketing y mantener las luces encendidas).
+2.9%
+127.0%
-760.9%
Margen netoEl porcentaje final que se lleva a casa. Cuando se eliminan todos los costos concebibles, impuestos y pagos de intereses, este es el número exacto de centavos que la empresa realmente se queda de cada dólar en ventas.
-8.2%
+67.1%
-566.1%
Flujo de caja libreEl santo grial del efectivo corporativo. Es el dinero físico gastable que queda después de que el negocio paga sus operaciones diarias Y compra las actualizaciones grandes y costosas (como nuevas fábricas o servidores) que necesita para sobrevivir. Este es el dinero 'libre' que pueden usar para pagar dividendos o recomprar acciones.
$365.3M
+2.2%
-44.2%
Margen FCFLa tasa definitiva de conversión de efectivo. Muestra qué tan buena es la empresa para convertir ventas regulares directamente en efectivo frío, duro y gastable. Un porcentaje alto significa que el negocio es una auténtica máquina de imprimir dinero.
+14.9%
+6.4%
-44.4%
Deuda/PatrimonioEl indicador de riesgo financiero. Compara cuánto del imperio de la empresa se construyó con dinero prestado (préstamos) frente al dinero propio de los propietarios (accionistas). Un número alto significa que están muy apalancados y juegan un juego más arriesgado; un número bajo significa que juegan a lo seguro.
92.5%
+3.5%
+3.7%
Ratio corrienteLa verificación de supervivencia de 12 meses. Simplemente compara el efectivo que tienen ahora mismo (más cosas que pueden convertirse rápidamente en efectivo) con las facturas inmediatas que absolutamente deben pagar este año. Una puntuación superior a 1 significa que tienen suficiente en la billetera para cubrir las próximas facturas sin entrar en pánico.
0.84x
-3.8%
+0.2%
Activos totalesEl tamaño absoluto del imperio de la empresa. Agrupa absolutamente todo lo valioso que poseen, desde el efectivo en la caja registradora y el inventario en el almacén, hasta las patentes de software en la bóveda y las fábricas en el suelo.
Operator: Hello, everyone. Thank you for joining us, and welcome to Clarivate's Q2 earnings conference call. After today's prepared remarks, we will host a question-and-answer session. To raise your hand, press star one. To withdraw your question, press star one again. I will now hand the conference over to Mark Donohue, Head of Investor Relations at Clarivate. Please go ahead.
Mark Donohue: Thank you, and good morning, everyone. Thank you for joining us for the Clarivate second quarter 2026 earnings conference call. As a reminder, this conference call is being recorded and webcast and is copyrighted property of Clarivate. Any rebroadcast of this information in whole or in part without prior written consent of Clarivate is prohibited. And the accompanying earnings call presentation is available on the Investor Relations section of the company's website. During our call, we may make certain forward-looking statements within the meaning of the applicable securities laws. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the business or developments in Clarivate's business to differ materially from the anticipated results, performance, achievements or developments expressed or implied by such forward-looking statements. Information about the factors that could cause actual results to differ materially from results and performance, can be found in Clarivate's filings with the SEC and on the company's website. Our discussion will include non-GAAP measures or adjusted numbers, Clarivate believes non-GAAP results are useful in order to enhance understanding of our ongoing operating performance but they are a supplement to and should not be considered in isolation from or as a substitute for GAAP financial measures. Reconciliation of these measures to GAAP measures are available in our earnings release and supplemental presentation on our website. With me today are Matti Shem Tov, Chief Executive Officer; Jonathan Collins, Chief Financial Officer and Michael Easton, Chief Accounting Officer. After our prepared remarks, we will open up the call to your questions. And with that, it is a pleasure to turn the call over to Matti.
Matti Shem Tov: Good morning, everyone, and thank you for joining us. The key messages today are straightforward. We are delivering on our commitment and now we have the building blocks in place to accelerate organic growth. During the quarter, we advanced our AI innovation roadmap, grew organic ACV year-over-year, maintained disciplined cost management, and strengthened our balance sheet through deleveraging. These actions will deliver further long-term value to shareholders. In the second quarter, we drove continued progress across the business. Organic ACV growth improved to 1.5% and profit margin has expanded to more than 42%. At the segment level, Academia & Government and Life Sciences & Healthcare, each delivered …